Request Demo
Last update 16 May 2026
MM-310
Last update 16 May 2026
Overview
Basic Info
Drug Type Antibody drug conjugate (ADC) |
Synonyms MM 310 |
Target |
Action antagonists |
Mechanism EphA2 antagonists(Ephrin type-A receptor 2 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Boost your research with our ADC technology data.
login
or
Related
1
Clinical Trials associated with MM-310NCT03076372
A Phase-1 Study Evaluating the Safety, Pharmacology and Preliminary Activity of MM-310 in Patients With Solid Tumors
100 Clinical Results associated with MM-310
Login to view more data
100 Translational Medicine associated with MM-310
Login to view more data
100 Patents (Medical) associated with MM-310
Login to view more data
100 Deals associated with MM-310
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Adenocarcinoma of prostate | Phase 1 | United States | 22 Feb 2017 | |
| Endometrial Carcinoma | Phase 1 | United States | 22 Feb 2017 | |
| Gastroesophageal junction adenocarcinoma | Phase 1 | United States | 22 Feb 2017 | |
| Non-Small Cell Lung Cancer | Phase 1 | United States | 22 Feb 2017 | |
| Ovarian Cancer | Phase 1 | United States | 22 Feb 2017 | |
| Pancreatic Ductal Adenocarcinoma | Phase 1 | United States | 22 Feb 2017 | |
| Small Cell Lung Cancer | Phase 1 | United States | 22 Feb 2017 | |
| Soft Tissue Sarcoma | Phase 1 | United States | 22 Feb 2017 | |
| Squamous Cell Carcinoma of Head and Neck | Phase 1 | United States | 22 Feb 2017 | |
| Triple Negative Breast Cancer | Phase 1 | United States | 22 Feb 2017 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free